Announce Date | 08/11/2025 |
EPS Normalized Actual | $0.05 (Miss by $-0.35) |
EPS GAAP Actual | $0.05 (Miss by $-0.35) |
Revenue Actual | $1.935B |
Revenue Surprise | Beat by $1935M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.41323 |
EPS GAAP Estimate | $0.41323 |
Revenue Estimate | $2.866874269B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 2.35 | 8.95 | 2.30434 | 2.38561 | 1 |
Dec 2027 | 1.8 | 11.69 | 1.76503 | 1.82728 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.19 | -0.227 | 1.935B | -41.5% | -967.15M |
FQ1 2025 (Mar 2025) | 0.17 | 0.17 | 2.352B | -16.28% | 2352M |
FQ4 2024 (Dec 2024) | -0.55 | -0.55 | 2.335B | -6.81% | 2335M |
FQ3 2024 (Sep 2024) | 0.0621 | 0.0621 | 2.476B | -7.79% | 2476M |
FQ2 2024 (Jun 2024) | 0.11 | 0.11 | 2.738B | -0.37% | 2738M |
FQ1 2024 (Mar 2024) | 0.0207 | 0.0207 | 2.735B | 3.33% | 2735M |
FQ4 2023 (Dec 2023) | -0.27 | -0.27 | 2.494B | -2.45% | 2494M |
FQ3 2023 (Sep 2023) | 0.13 | 0.13 | 2.669B | 5.02% | 2669M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.41323
Consensus Revenue Estimates
2.866874269B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.84 | -- | 0.81874 | 0.85756 | 1 |
FQ3 2027 (Sep 2027) | 0.71 | -- | 0.69141 | 0.72626 | 1 |
FQ2 2027 (Jun 2027) | 0.59 | -- | 0.57455 | 0.60351 | 1 |
FQ1 2027 (Mar 2027) | 0.43 | -- | 0.41874 | 0.43985 | 1 |
FQ4 2026 (Oct 2026) | 0.5 | -- | 0.49136 | 0.50967 | 0 |
FQ3 2026 (Jul 2026) | 0.54 | -- | 0.53067 | 0.55044 | 0 |
FQ2 2026 (Jun 2026) | 0.57 | 66.67 | 0.55637 | 0.58359 | 0 |
FQ1 2026 (Mar 2026) | 0.45 | 62.22 | 0.43924 | 0.46073 | 0 |
FQ4 2025 (Oct 2025) | 0.41195 | 233.51 | 0.40483 | 0.41992 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.92B | -- | 1.88B | 1.95B | 2 |
FQ3 2027 (Sep 2027) | 2.65B | -- | 2.59B | 2.69B | 2 |
FQ2 2027 (Jun 2027) | 2.56B | -- | 2.51B | 2.6B | 2 |
FQ1 2027 (Mar 2027) | 2.41B | -- | 2.36B | 2.45B | 2 |
FQ4 2026 (Oct 2026) | 2.91B | -- | 2.87B | 2.95B | 2 |
FQ3 2026 (Jul 2026) | 3.03B | -- | 2.99B | 3.08B | 2 |
FQ2 2026 (Jun 2026) | 3.05B | 36.59 | 3B | 3.11B | 2 |
FQ1 2026 (Mar 2026) | 2.87B | 17.92 | 2.81B | 2.92B | 2 |
FQ4 2025 (Oct 2025) | 2.79B | 16.42 | 2.76B | 2.84B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.417 | 0.19 | -0.227 | -119.47% |
FQ1 2025 (Mar 2025) | 0.17 | 0.17 | 100% | |
FQ4 2024 (Dec 2024) | -0.55 | -0.55 | 100% | |
FQ3 2024 (Sep 2024) | 0.0621 | 0.0621 | 100% | |
FQ2 2024 (Jun 2024) | 0.11 | 0.11 | 100% | |
FQ1 2024 (Mar 2024) | 0.0207 | 0.0207 | 100% | |
FQ4 2023 (Dec 2023) | -0.27 | -0.27 | 100% | |
FQ3 2023 (Sep 2023) | 0.13 | 0.13 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $2.9B | $1.94B | $-967.15M | -49.98% |
FQ1 2025 (Mar 2025) | $0B | $2.35B | $2352M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.34B | $2335M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.48B | $2476M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.74B | $2738M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.74B | $2735M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.49B | $2494M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.67B | $2669M | 100% |